No Data
*ST Longjin: 2024 Third Quarter Report
*ST Longjin: 2024 Semi-Annual Report Summary
*ST Longjin: 2024 Semi-Annual Report
ST Longjin (002750.SZ): Net loss of 4.224 million yuan in the first half of the year.
Geelong reported its semi-annual report for 2024 on August 27th. The report shows a revenue of 39.4178 million yuan for the reporting period, a decrease of 9.66% year-on-year. The net income attributable to the company's shareholders is -4.224 million yuan, with a narrowed loss year-on-year. The net income attributable to the company's shareholders after deducting non-recurring gains and losses is -11.4206 million yuan. The basic earnings per share is -0.0105 yuan.
ST Longjin (002750.SZ) released its performance for the first half of the year, with a net loss of 4.224 million yuan.
*ST Longjin (002750.SZ) released its 2024 semi-annual report, during the reporting period, the company achieved operating income...
Special treat Longjin (002750.SZ): As of August 9, the number of shareholders in the company was 38,065.
On August 14th, Gelunhui reported that as of the latest date of August 9, 2024, the number of shareholders in Special Treat Longjin (002750.SZ) was 38,065.
Kunming Longjin Pharmaceutical Co., Ltd.'s (SZSE:002750) Share Price Not Quite Adding UpNo Data
No Data
